Overview

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

Status:
Completed

Trial end date:
2006-04-01

Target enrollment:

Participant gender:

Summary

This study is being carried out to see if quetiapine (Seroquel) is effective in preventing patients from a schizophrenic relapse when studied for a long time (1 year) and if so, how it compares with non-active treatment.

Phase:

Phase 3

Details

Lead Sponsor:

AstraZeneca

Treatments:

Quetiapine Fumarate